Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma

• Status: Recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

This research is a clinical study with a single-blind randomized clinical trial design (randomized controlled trial) in multicenters at two Dermatology and Venereology Education centers in Indonesia.

This study aims to determine the effectiveness and safety of PSP as adjuvant therapy for melasma.

This research will be attended by 33 research subjects

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Dr.dr.Irma Bernadette, SpKK (K)
• Collaborator: Menarini Group

Criteria

Inclusion Criteria:

1. women aged 30-60 years

2. Fitzpatrick skin phototype IV-V

3. Diagnosis of epidermal, mixed and dermal types of Melasma

Exclusion Criteria:

1. Are pregnant or breastfeeding

2. Use other lightening agents, both oral and topical

3. Allergy to PSP content

4. Use of other topical therapies for skin disorders may interfere with the evaluation of melasma conditions

5. Suffering from other skin diseases such as acne, dermatitis

6. Using hormonal birth control